Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ronald, Waksman"'
Autor:
Michael Mack, Art Sedrakyan, Gregory Pappas, Jesse Berlin, Erika Avila-Tang, John Carroll, Joseph Drozda, Douglas Dumont, Thomas Gross, Kathleen Hewitt, Ajay Kirtane, David Kong, Mitchell Krucoff, John Lashinger, Nellie Lew, Fred Masoudi, Danica Marinac-Dabic, Roxanna Mehran, Sharon-Lise Normand, Elizabeth Quin, Fred Resnic, Ronald Waksman, Larry Wood, Changfu Wu, Tianay Ziegler
Publikováno v:
BMJ Surgery, Interventions, & Health Technologies, Vol 1, Iss 1 (2019)
Background The Transcatheter Valve Therapy (TVT) Coordinated Registry Network (CRN) supported 23 regulatory decisions and ensured evidence-based evaluation of the application of TVT technology. However, there are cost concerns that require value asse
Externí odkaz:
https://doaj.org/article/6c16e90fc9544574998a6df257247be3
Autor:
Thomas G. Gross, Nellie Lew, Erika Avila-Tang, Elizabeth Quin, Art Sedrakyan, Frederick A. Masoudi, Ajay J. Kirtane, R. Mehran, Gregory Pappas, Ronald Waksman, John D. Carroll, Kathleen Hewitt, Sharon-Lise T. Normand, John Lashinger, Michael J. Mack, Jesse A. Berlin, Douglas Dumont, Fred Resnic, Tianay Ziegler, Larry Wood, Mitchell W. Krucoff, Changfu Wu, Danica Marinac-Dabic, David F. Kong, Joseph P. Drozda
Publikováno v:
BMJ Surgery, Interventions, & Health Technologies
BackgroundThe Transcatheter Valve Therapy (TVT) Coordinated Registry Network (CRN) supported 23 regulatory decisions and ensured evidence-based evaluation of the application of TVT technology. However, there are cost concerns that require value asses
Autor:
Michael J. Pencina, Peter B. Berger, Donald E. Cutlip, Victor Novack, Mirle A. Kellett, Mun K. Hong, Steven L. Goldberg, Ronald Waksman, David J. Cohen, Neal S. Kleiman, Chen Hsing Yen, Albert E. Raizner, Laura Mauri
Publikováno v:
JACC: Cardiovascular Interventions. 2(8):767-775
Objectives The aim of this study was to compare outcomes among unselected patients undergoing percutaneous coronary intervention (PCI) with either sirolimus-eluting (SES) or paclitaxel-eluting stents (PES). Background Although the benefits of both SE
Autor:
Michael D. Dake, Stephen R. Ramee, Ronald Waksman, Bruce H. Gray, Michael S. Conte, John H. Rundback, Krishna Kandarpa, Michael R. Jaff
Publikováno v:
Circulation. 118:2864-2872
Percutaneous intervention for peripheral artery disease has evolved from balloon angioplasty for simple focal lesions to multimodality techniques that enable treatment of severe arterial insufficiency. This technological expansion comes without a sta
Autor:
Victor, Novack, Donald, Cutlip, Neal, Kleiman, Michael, Pencina, Laura, Mauri, Chen-Hsing, Yen, Peter, Berger, Steven, Goldberg, Mirle, Kellett, Ronald, Waksman, Mun, Hong, Albert E, Raizner, David J, Cohen
Publikováno v:
JACC. Cardiovascular interventions. 2(8)
The aim of this study was to compare outcomes among unselected patients undergoing percutaneous coronary intervention (PCI) with either sirolimus-eluting (SES) or paclitaxel-eluting stents (PES).Although the benefits of both SES and PES are well-esta
Publikováno v:
The Vulnerable Atherosclerotic Plaque: Strategies for Diagnosis and Management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a75490e3a6d0fca3378a5e157915aa1
https://doi.org/10.1002/9780470987575.ch24
https://doi.org/10.1002/9780470987575.ch24